Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans.

Results suggest that LAI naltrexone is associated with increased time to relapse and should be considered as a first-line option for patients. Given the retrospective nature and small sample size of this study, larger, randomized, controlled trials comparing LAI and oral naltrexone head to head would help determine most appropriate treatment for these patients.